These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 24232037

  • 1. Radiofrequency ablation after arterial injection of miriplatin-iodized oil suspension into swine liver: ablative zone size and tissue platinum concentration.
    Yamanaka T, Takaki H, Nakatsuka A, Uchida K, Junji U, Fujimori M, Hasegawa T, Yoneda M, Shiraishi T, Sakuma H, Yamakado K.
    Cardiovasc Intervent Radiol; 2014 Aug; 37(4):1047-52. PubMed ID: 24232037
    [Abstract] [Full Text] [Related]

  • 2. Combination therapy by transarterial injection of miriplatin-iodized oil suspension with radiofrequency ablation (RFA) versus microwave ablation (MWA) for small hepatocellular carcinoma: a comparison of therapeutic efficacy.
    Miyamoto N, Kanaya M, Fujii T, Kato H, Kudo K, Kinota N.
    Jpn J Radiol; 2021 Apr; 39(4):376-386. PubMed ID: 33150469
    [Abstract] [Full Text] [Related]

  • 3. Extension of radiofrequency ablation of the liver by transcatheter arterial embolization with iodized oil and gelatin sponge: results in a pig model.
    Sugimori K, Nozawa A, Morimoto M, Shirato K, Kokawa A, Saito T, Numata K, Tanaka K.
    J Vasc Interv Radiol; 2005 Jun; 16(6):849-56. PubMed ID: 15947049
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical utility of radiofrequency ablation following transarterial injection of miriplatin-iodized oil suspension in small hepatocellular carcinoma.
    Nakajima K, Yamanaka T, Nakatsuka A, Haruyuki T, Fujimori M, Sugino Y, Matsushita N, Sakuma H, Isaji S, Takei Y, Yamakado K.
    Jpn J Radiol; 2016 Sep; 34(9):640-6. PubMed ID: 27455985
    [Abstract] [Full Text] [Related]

  • 6. Radiofrequency ablation combined with reduction of hepatic blood flow: effect of Lipiodol on coagulation diameter and ablation time in normal pig liver.
    Chung H, Kudo M, Minami Y, Kawasaki T.
    Hepatogastroenterology; 2007 Sep; 54(75):701-4. PubMed ID: 17591045
    [Abstract] [Full Text] [Related]

  • 7. [Experimental study on optimal operating parameters setting of radiofrequency thermal ablation in normal ex-swine livers].
    Liang HH, Chen MS, Zhang YQ, Guo RP, Li GH.
    Ai Zheng; 2005 Jan; 24(1):12-8. PubMed ID: 15642193
    [Abstract] [Full Text] [Related]

  • 8. Computed tomography fluoroscopy-guided radiofrequency ablation following intra-arterial iodized-oil injection for hepatocellular carcinomas invisible on ultrasonographic images.
    Takaki H, Yamakado K, Nakatsuka A, Yamada T, Uraki J, Kashima M, Yamanaka T, Shiraki K, Takei Y, Takeda K.
    Int J Clin Oncol; 2013 Feb; 18(1):46-53. PubMed ID: 22016114
    [Abstract] [Full Text] [Related]

  • 9. Combination radiofrequency ablation with intratumoral liposomal doxorubicin: effect on drug accumulation and coagulation in multiple tissues and tumor types in animals.
    Ahmed M, Liu Z, Lukyanov AN, Signoretti S, Horkan C, Monsky WL, Torchilin VP, Goldberg SN.
    Radiology; 2005 May; 235(2):469-77. PubMed ID: 15858089
    [Abstract] [Full Text] [Related]

  • 10. Radiofrequency ablation of the liver: extended effect of transcatheter arterial embolization with iodized oil and gelatin sponge on histopathologic changes during follow-up in a pig model.
    Morimoto M, Numata K, Nozawa A, Kondo M, Nozaki A, Nakano M, Tanaka K.
    J Vasc Interv Radiol; 2010 Nov; 21(11):1716-24. PubMed ID: 20884228
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma.
    Shiraishi R, Yamasaki T, Saeki I, Okita K, Yamaguchi Y, Uchida K, Terai S, Sakaida I.
    Am J Clin Oncol; 2008 Aug; 31(4):311-6. PubMed ID: 18845987
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Assessment of ablative margin after radiofrequency ablation for hepatocellular carcinoma; comparison between magnetic resonance imaging with ferucarbotran and enhanced CT with iodized oil deposition.
    Koda M, Tokunaga S, Fujise Y, Kato J, Matono T, Sugihara T, Nagahara T, Ueki M, Murawaki Y, Kakite S, Yamashita E.
    Eur J Radiol; 2012 Jul; 81(7):1400-4. PubMed ID: 21440397
    [Abstract] [Full Text] [Related]

  • 15. Experimental assessment of temperature influence on miriplatin and cisplatin iodized-oil suspension viscosity.
    Hasegawa T, Takaki H, Yamanaka T, Fujimori M, Nakatsuka A, Uraki J, Yamada T, Sakuma H, Yamakado K.
    Jpn J Radiol; 2013 Jun; 31(6):424-7. PubMed ID: 23525952
    [Abstract] [Full Text] [Related]

  • 16. Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of tumors implanted in rat livers by inducing platinum-DNA adducts to form and massive apoptosis.
    Hanada M, Baba A, Tsutsumishita Y, Noguchi T, Yamaoka T, Chiba N, Nishikaku F.
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):473-83. PubMed ID: 19104812
    [Abstract] [Full Text] [Related]

  • 17. Increased ablation zones using a cryo-based internally cooled bipolar RF applicator in ex vivo bovine liver.
    Rempp H, Voigtländer M, Clasen S, Kempf S, Neugebauer A, Schraml C, Schmidt D, Claussen CD, Enderle MD, Goldberg SN, Pereira PL.
    Invest Radiol; 2009 Dec; 44(12):763-8. PubMed ID: 19838120
    [Abstract] [Full Text] [Related]

  • 18. Enhancement of radiofrequency ablation of the liver combined with transarterial embolization using various embolic agents.
    Irie K, Morimoto M, Numata K, Kondo M, Moriya S, Shimoyama Y, Nozaki A, Goda Y, Kobayashi S, Ueno M, Ohkawa S, Tanaka K, Maeda S.
    Abdom Imaging; 2015 Aug; 40(6):1821-8. PubMed ID: 25526685
    [Abstract] [Full Text] [Related]

  • 19. Antitumor effect of miriplatin-lipiodol suspension/emulsion using a VX2 liver tumor model.
    Tomozawa Y, Nitta N, Ohta S, Otani H, Watanabe S, Sonoda A, Tsuchiya K, Nitta-Seko A, Takahashi M, Murata K.
    Jpn J Radiol; 2013 Oct; 31(10):662-7. PubMed ID: 23828788
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the anti-tumor effects of two platinum agents (miriplatin and fine-powder cisplatin).
    Watanabe S, Nitta N, Ohta S, Sonoda A, Otani H, Tomozawa Y, Nitta-Seko A, Tsuchiya K, Tanka T, Takahashi M, Murata K.
    Cardiovasc Intervent Radiol; 2012 Apr; 35(2):399-405. PubMed ID: 21584842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.